VOLITIONRX LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.746 USD | +3.10% |
|
-7.24% | +3.50% |
| 14/05 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
| 13/05 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechUnknown Analyst (Analysts)Joining us next out of Austin, Texas, is a multinati...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Calendar
02/07/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.7236
USD
Average target price
3.633
USD
Spread / Average Target
+402.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.50% | 59.93M | |
| -31.70% | 9.87B | |
| -16.78% | 2.75B | |
| -17.50% | 2.13B | |
| -24.68% | 1.65B | |
| +65.88% | 1.47B | |
| +32.58% | 811M | |
| -5.02% | 733M | |
| -30.10% | 510M | |
| +0.20% | 300M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- Transcript : VolitionRx Limited Presents at LD Micro 500 Virtual Investor Conference, Sep-01-2020 09
